Skip to content
WeighLab
Menu
Ranked #33 · Grade B−

REMEVi review

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Visit REMEVi Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$219/mo
Tirzepatide
$319/mo
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,628

Tirzepatide · modeled / year

$3,828

Pricing verified August 2026

The Index scorecard

REMEVi scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month65/100
Price Transparency94/100
Nationwide Access86/100
Formulation Options77/100
Clinical Oversight87/100
Contract Flexibility69/100

Where the value is

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
  • A daily oral semaglutide tablet is offered alongside the injection
  • Available in all 50 states and DC, with no minimum commitment and no cancellation fee

The tradeoffs

  • The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

The bottom line

Best for: Cost-first shoppers who want bilingual, LegitScript-certified compounded GLP-1. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Ranked #33 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to REMEVi.

The 22 programs nearest this one

Pricing, states and verification reflect REMEVi's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.

← Back to the value leaderboard